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The pinna (or auricle) is part of the external ear, acting to capture and funnel
sound toward the middle ear. The pinna is defective in a number of craniofacial
syndromes, including Lacrimo-auriculo-dento-digital (LADD) syndrome, which is caused
by mutations in FGF10 or its receptor FGFR2b. Here we study pinna defects in the Fgf10
knockout mouse. We show that Fgf10 is expressed in both the muscles and forming
cartilage of the developing external ear, with loss of signaling leading to a failure in
the normal extension of the pinna over the ear canal. Conditional knockout of Fgf10
in the neural crest fails to recapitulate this phenotype, suggesting that the defect is
due to loss of Fgf10 from the muscles, or that this source of Fgf10 can compensate
for loss in the forming cartilage. The defect in the Fgf10 null mouse is driven by a
reduction in proliferation, rather than an increase in cell death, which can be partially
phenocopied by inhibiting cell proliferation in explant culture. Overall, we highlight the
mechanisms that could lead to the phenotype observed in LADD syndrome patients
and potentially explain the formation of similar low-set and cup shaped ears observed
in other syndromes.
Keywords: ear development, auricle, congenital birth defect, muscle, fibroblast growth factor, microtia
INTRODUCTION
Microtia is a common congenital birth defect, wherein the external pinna (or auricle) is small
and/or abnormally formed. It is observed with an incidence of 0.83–17.4 per 10,000 births,
depending on geographical location (Luquetti et al., 2012). 12.6% of microtia patients have an
underlying craniofacial syndrome (Cabrejo et al., 2019). Microtia is often associated with defects
in the middle ear, which together can lead to conductive hearing loss (Cox et al., 2014). During
the process of hearing, the pinna acts as a funnel, and can also provide information regarding the
location of sound (Hofman et al., 1998). In addition, in human beings, the pinna plays a major role
in our appearance, and as such abnormally shaped pinnas impact on daily life. Microtia is treated
by ear reconstruction surgery or the use of ear molds in infants to correct the shape of the pinna
(Chan et al., 2019). Ear surgery is challenging because the pinna’s appearance varies considerably
between patients.
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The pinna is part of the outer ear, which also contains the
ear canal and tympanic membrane. A true pinna is only found
in therian mammals (marsupials and eutherians), and is thought
to have developed after their evolutionary divergence from the
egg laying monotremes (Mozaffari et al., 2020). The pinna derives
largely from the second pharyngeal arch in mouse, while it is
thought to develop from the first and second pharyngeal arch in
humans, with the tragus being first arch derived (Minoux et al.,
2013). The mouse pinna develops slightly differently from the
human pinna. In the mouse, the pinna initiates at Embryonic day
(E)11.5. As the mouse pinna grows it bends toward the rostral
part of the head, extending a flap over the ear canal to cover the
ear canal completely by E18.5 (Cox et al., 2014). The pinna then
fuses to the side of the head and remains, encasing the ear canal
until postnatal stages. At 3–5 days postnatally, the pinna flap
detaches from the head, lifts up and flips back to reach its adult
position (Anthwal and Thompson, 2016). The pinna continues
to grow postnatally reaching its adult shape and size at around
postnatal day 14. In humans, the main part of the pinna remains
posterior to the ear canal during development, forming a complex
folded structure (Cox et al., 2014), with the majority of growth
completed by 9 years old. However, pinnae continue to grow and
male pinnae are bigger than female (Sforza et al., 2009).
Several craniofacial syndromes are associated with pinna
defects, such as Lacrimo-auriculo-dento-digital syndrome
(LADD) (MIN14970), Branchio-oto-renal (BOR) syndrome
and 22q11.2 deletion syndrome amongst others (Thompson
et al., 1985; Oskarsdottir et al., 2008; Galliani et al., 2012).
LADD syndrome is an autosomal-dominant multiple congenital
anomaly disorder characterized by defects in lacrimal and
salivary glands, the dentition, digits and ear (Milunsky et al.,
2006). The main malformation of the pinna is the presence of a
cup-shaped ear which is often low-set (Inan et al., 2006). LADD
syndrome has been shown to be caused by defects in the FGF
(fibroblast growth factor) signaling pathway, with mutations
in FGF10 and its receptor FGFR2b, both leading to the same
phenotype (Milunsky et al., 2006; Rohmann et al., 2006). In
mouse development, Fgf10 is expressed in the glands, limb and
in the forming pinna (El Agha et al., 2012; Teshima et al., 2016).
Knockout of Fgf10 in the mouse, leads to defects in glands
and teeth (Ohuchi et al., 2000), although the pinna has been
suggested to develop as normal (Prochazkova et al., 2018).
Fgf10 is a secreted protein composed of 250 amino acids
usually acting in a paracrine manner (Yamasaki et al., 1996). It
belongs to the Fgf7/10/22 subfamily of Fibroblast growth factors
(Itoh and Ornitz, 2008). Fgf10 plays a role in mesenchymal to
epithelial interaction, important in many developing tissues and
organs (Itoh, 2016). The Fgf10 null mutant mouse dies at birth
due to the absence of lungs, while conditional loss of Fgf10 in
the neural crest, mirrors a subset of the phenotype and leads
to a similar death at birth due to the presence of a cleft palate
(Teshima et al., 2016). In addition to lung defects, mutations
in Fgf10 cause limb aplasia due to a deregulation of the apical
ectodermal ridge (AER) (Sekine et al., 1999). Mesenchymal Fgf10
in the progress zone signals to the AER through Fgfr2b to
upregulate Wnt3a-Fgf8 axis that then feeds back to regulate Fgf10
expression (Jin et al., 2018). In the salivary gland, loss of Fgf10
leads to an arrest of gland development at the placode stage,
with downregulation of Sox9 expression in the distal epithelial
compartment (Chatzeli et al., 2017).
FGF signaling in embryogenesis is considered to be
transduced by three major pathways, PLC γ, PI3Kinase/PKB
and RAS/ERK1/2 [MAP (mitogen-activated protein) Kinase]
(Bottcher and Niehrs, 2005). ERK1/2 has been shown to relay
signaling from FGF receptors in early fish, frog, chick and
mouse embryos (Christen and Slack, 1999; Corson et al., 2003;
Lunn et al., 2007). In the lung, mesenchymal Fgf10 signals to
the epithelium through Fgfr2b to promote proliferation and
differentiation by activating the MAP kinase signaling pathway
(Yin and Ornitz, 2020). MAPK signaling consists of a series
of phosphorylation cascades involving 3 kinases, RAF, MEK
1/2 and MAP (ERK1/2) kinases. After nuclear translocation,
p-ERK1/2 activates gene transcription of the PEA3 sub-family
(PEA3/ETV4, ERM/ETV5 and ER81/ETV1), which have been
utilized as readouts of FGF activity (Lunn et al., 2007). Mutations
in Erk1/2 mimic the defects observed in patients with 22q11.2
deletion syndrome, one of the craniofacial syndromes associate
with microtia (Newbern et al., 2008). Defects in FGF signaling,
acting via the RAS/ERK pathway, may, therefore, underlie the
ear phenotype in both LADD syndrome and 22q11.2DS.
In this study we have investigated pinna development in Fgf10
knockout mice in order to understand potential mechanisms
involved in LADD syndrome. We highlight the source of Fgf10,
the tissues that respond to Fgf10 signaling in the ear, and the cell
processes affected. The Fgf10 knockout mouse can therefore be
used as a model to study the mechanisms underlying the pinna
defect in LADD syndrome patients, and other syndromes with
low set, cup shaped ears.
MATERIALS AND METHODS
Animals
Fgf10+/− mouse were intercrossed to generate Fgf10 null
embryos. Fgf10+/− and Fgf10+/+ mice were both used as a
control group for Fgf10−/− as the heterozygous mice have
normal pinnae. The reduction of Fgf10 in the heterozygous mice
leads to defects in gland development but does not affect breeding
(May et al., 2015). Fgf10f l/fl females (Fgf10A02 tmc1c) were
crossed to Wnt1cre; Fgf10f l/+ to generate Wnt1cre; Fgf10f l/fl and
Fgf10f l/fl used as controls (Teshima et al., 2016). To confirm the
neural crest origin of the mesenchyme of the pinna, Wnt1cre
mice were mated to R26RtdTom reporter mice. The matings were
set up in the evening and the day of the vaginal plug observed
was marked as E0.5. Pregnant females were culled with Schedule
I culling methods at E14.5, E15.5, and E18.5. After culling, all
embryos were photographed on a Leica dissecting microscope.
Histology
After collection embryos were fixed in 4% paraformaldehyde
(PFA) and then dehydrated in gradually increasing Ethanol
concentrations (30, 50, 70, 90, 95, and 100% 1 h per step).
Embryos were cleared in xylene and embedded in paraffin.
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Sections were cut at 8µm and stained with Alcian Blue, Sirius Red
and Ehrlich’s Haematoxylin.
LacZ Staining
Heads from Fgf10nlacZ/+ mice (Kelly et al., 2001), were fixed in
4% PFA for 20 min, N = 3. To stain heads were washed twice for
20 min in PBS with 2 mM MgCl2. Heads were then incubated
for 15 min in a solution containing 1 mM MgCl2, 0.2% NP-40
and 0.02% deoxycholic acid diluted in PBS (Solution B), and then
stained with Solution C made with 5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6 and 1 mg/ml x-gal diluted in Solution B. Staining was
performed at 37oC for 4 h. Using the same protocol, cryosections
on slides were additionally stained at 37oC for 4 days to increase
the intensity of the signal, washed in PBS and re-fixed.
Immunofluorescence and in situ
Hybridization
Primary antibodies used include anti-BrdU (ab6326, abcam),
anti-Caspase 3 (9661s, Cell Signaling Technology), anti-12-101
(AB_531892, DSHB), and anti-SOX9 (AB5535, Millipore), β-gal
(ab9361, abcam), anti-P-p44/42 MAPK (9101s, Cell signaling)
and anti-RFP (red fluorescent protein) (Chromotek 5f8-100).
For Caspase 3, the signal was amplified with a TSA kit
(PerkinElmer). For BrdU, 2M HCl at 37oC was used before
addition of the primary antibody. In situ hybridization was
performed as previously described (Fons Romero et al., 2017).
Immunolabelings and in situ hybridization reactions were
repeated at least 3 times to confirm the expression patterns.
Rolling Explant Culture
In order to culture the whole pinna we used a novel rotational
tissue culture system. CD1 pregnant females were sacrificed
at E12.5. After halving the heads and removing the brain,
embryos were place in KO-DMEM (A12861-01) medium in
Falcon tubes. Proliferation inhibitor (Aphidicolin, sc-201535)(2
µg/ml) disolved in DMSO was applied to one group (N = 6) and
DMSO (carrier) as a control to the other group (N = 16). Tubes
were incubated at 37◦C with 95% O2 and 5%CO2 gas (Carbogen)
and rotated at 25 rpm to improve circulation for 2 days.
Proliferation Analysis
For the Fgf10 embryos at E14.5 and E15.5, pregnant females
were IP injected with BrdU (30 mg/kg) 1 h before collection.
Embryos were sectioned and immunostained for BrdU by IF
and imaged. Defined groups of cells within the pinna were
demarcated using a standardized method (see Supplementary
Figure 1 for method used to define a standardized area for
counting). The total number of nuclei that were BrdU positive
within the defined region was counted on up to 10 continuous
sections for each embryo using ImageJ. Counts for each embryo
were then averaged and the average number of proliferating cells
compared across littermates (N = 3–4 embryos per group).
Statistics
A Student’s two tailed unpaired t-test was used for the
proliferation comparison. Fisher exact probability was
performed for comparisons. A significant difference was
taken as P < 0.05 (∗).
RESULTS
Fgf10 Is Expressed in the Developing
Muscle and Cartilaginous Condensations
of the Pinna
Previously, an Fgf10icre/Tom mouse has been used to show
widespread expression of Fgf10 in the developing pinna at
E18.5, traced from E15.5 (El Agha et al., 2012). To get a more
detailed understanding of the expression of Fgf10 during pinna
development we used Fgf10LacZ reporter mice, where LacZ
is under the control of Fgf10 regulatory sequences without
disrupting Fgf10 function (Kelly et al., 2001). Fgf10 was expressed
at high levels in the forming pinna at E (embryonic day)
14.5 (Figures 1A,B, asterisk), in addition to the surrounding
craniofacial muscles (Figure 1A arrowheads). In section, at
different planes through the pinna (see Figure 1C), a band of
positive expression was evident following the curve of the pinna
(Figures 1D–F, arrow in Figure 1D). In addition, Fgf10 was
expressed in the developing cartilage extending from the base
of the pinna (basal cartilage, bc) to the tip of the pinna (distal
cartilage, dc) (Figures 1D–F, arrowhead in Figure 1D).
In order to confirm the expression of Fgf10 in the two different
regions we compared the expression of LacZ with markers
for early cartilage (Sox9) and differentiated muscle (12–101)
(Kintner and Brockes, 1984; Lefebvre et al., 2019). Overlap of
Sox9 and LacZ was found at the base of the pinna (Figures 1H–
J,Q–T), confirming that some cartilage cells expressed Fgf10.
Interestingly, we did not detect Sox9 expression in the cell
condensates in the distal cartilage of the pinna (dc) at this stage
of development, although Sox9 was upregulated in this region
at later stages (data not shown), suggesting that Fgf10 predated
Sox9 expression in this region. A convincing overlap was evident
between 12–101 and LacZ, highlighting the expression of Fgf10
in the pinna muscle (Figures 1H,K,L,M–P). Fgf10 is therefore
expressed in two populations in the developing pinna, the
mesodermally-derived muscles of the growing pinna, and the
neural crest-derived cartilage.
Lack of Fgf10 Results in a Shorter Pinna
but Without Loss of Sox9 and 12–101
Previous analysis of the pinna in Fgf10 knockout mice has
not described a defect, and in keeping with this the pinna of
Fgf10 null mutants appeared normal at E14.5 (Figures 2A,B,E,F)
(N = 5). Fgf10, therefore, does not appear to be involved in early
initiation of the ear in mice. A phenotype, however, was evident
from E15.5 (Figures 2C,D,G,H). By E15.5 in controls, the pinna
had extended forward over the ear canal toward the prospective
tragus, so that the opening was no longer evident (Figure 2C)
(N = 6). In contrast, in the mutant the pinna did not extend
leaving the ear canal exposed (Figures 2D,G,H, double arrow
head) (N = 4). In section, the pinna was fused to the rest of
the head in the controls, however, the mutant pinna remained
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FIGURE 1 | Fgf10 is expressed in auricular muscle and cartilage. (A,B) Whole mount βGal staining of Fgf10-LacZ reporter mouse at E14.5. Fgf10 is expressed in the
pinna (asterisk) and the surrounding muscles (arrowheads). (C) µCT 3D reconstruction of a E14.5 embryo showing the level and plane of the respective sections.
(D–F) Wax sections stained for βGal. Posterior is up, anterior is down. Fgf10 is expressed in the basal (bc) and distal cartilage (dc) and in the pinna muscle (m). Pinna
tip = (p). (H) Triple IF for βGal (green), Sox9 (magenta) and 12–101 (red). (I–L) Higher magnification of boxed regions in (H). (I,J) Fgf10 expression colocalizes with the
cartilage marker Sox9 in the basal cartilage. (K,L) Fgf10 expression colocalizes with the muscle marker 12–101 in the pinna muscle. (M–T) Close up of the
developing pinna muscle (M–P) and basal cartilage (Q–T). (M,Q) DAPI showing nuclei in selected region. (N) 12–101 9 (red). (O) βGal (green). (P) Overlap between
12–101 and βGal. (R) Sox9 (magenta). (S) βGal (green). (T) Partial overlap between Sox9 and βGal. Scale bar in D = 100 µm.
detached from the head (compare Asterisk in Figures 2G,H) and
far from the forming ear canal (arrowheads Figures 2G,H). The
histology at all stages analyzed indicated formation of muscle
and cartilage, which was confirmed by expression of the cartilage
marker Sox9 and terminally differentiated muscle marker 12–101
(Figures 2I–L). Expression of muscle and cartilage markers was
therefore unaffected by loss of Fgf10. In addition to its expression
in cartilage, Sox9 was also expressed in the fused epithelium of the
inner pinna at E15.5, while expression was not observed in this
region prior to fusion (at E14.5) or in the unfused mutant at E15.5
(Figures 2I,K,L). Sox9 may therefore play an additional role in
fusion of the pinna epithelium. By E18.5, the pinna was observed
fused to the head in both mutant and wild-type littermates,
however, the ear canal remained exposed and the pinna had
failed to meet the future tragus in the mutants (Figures 2O,P,S,T)
(N = 1).
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FIGURE 2 | Fgf10 is required for pinna elongation. (A–D) whole mount pinnae at E14.5 (A,B) and E15.5 (C,D) of a Fgf10 null mutant (B,D) and control littermate
(A,C). The phenotype start to be visible at E15.5 with a defect in the anterior elongation of the pinna (C,D arrow). (E–H) Trichrome staining. The defect in elongation
is clear at E15.5 (G,H double arrow head). (I–L) Double IF for Sox9 and 12–101. Both markers are expressed in comparable domains to the wildtype. (M) Fgf10 fl/fl
control at E18.5. (N) Wnt1cre/+ Fgf10 fl/fl at E18.5. (O) Fgf10 control E18.5. (P) Fgf10 null mutant at E18.5. (Q–T) Trichrome staining. Ablation of Fgf10 in the neural
crest cells does not phenocopy the elongation defects in the Fgf10 null mutant (P,T arrow). (BP) basal pinna (DP) distal pinna. Asterisk labels the inner epithelial layer
of the pinna that fuses with the adjacent head epithelium. (C) Forming cartilage. (M) forming muscle. Scale bar in (E–H,I,Q–T) = 100 µm. Same scale in (J–L).
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In order to distinguish the role of mesodermal Fgf10 from
the neural crest derived Fgf10 (Figure 1) we used a conditional
approach to ablate Fgf10 specifically in the cranial neural
crest using Wnt1cre (Figures 2M,N,Q,R) (Teshima et al.,
2016). The cartilage of the pinna is formed from neural
crest derived mesenchyme, while the muscles are non-neural
crest derivatives (Supplementary Figure 2). Agreeing with the
previously published phenotype, the conditional mutants had
cleft palates, confirming that that Fgf10 had been deleted in
the cranial neural crest (Supplementary Figure 3). In this
conditional mutant, the pinna appeared identical to that of
control littermates, in contrast with the Fgf10 null mutants at
this timepoint (Figures 2Q–T). Loss of Fgf10 specifically in the
neural crest population, therefore, had limited effect on pinna
development (N = 2). This suggests that mesodermal Fgf10 is
the main source of Fgf10 for pinna elongation, or that in the
absence of a source from the neural crest, mesodermal Fgf10 can
compensate for any loss.
Pinna Extension Defect Is Caused by
Reduced Cell Proliferation, Rather Than
Cell Death
FGFs are known to have a role in controlling both proliferation
and apoptosis (Prochazkova et al., 2018). We therefore
investigated whether proliferation and cell death were altered
in the Fgf10 null mutants using BrdU and activated Caspase 3.
Since the phenotype started to be evident at E15.5, we analyzed
proliferation at two stages, E14.5 and E15.5. As expected from a
growing structure, high levels of cell proliferation were present
in the epithelium and adjacent mesenchyme in control embryos
at E14.5 and E15.5 (Figures 3A,B,F,G). In contrast, in the
mutant embryos a reduction in proliferation was evident. To
quantify this change, cells were counted in defined regions at
the tip (boxes in Figures 3B,D,G,I), and at the sides (boxes
in Supplementary Figure 4A) of the pinna (N = 3–4 embryos
per group). Proliferation of both epithelial and mesenchymal
cells was significantly reduced compared to the controls at both
stages analyzed in the epithelium and mesenchyme, suggesting
that the proliferation defect at E14.5 might drive the phenotype
at E15.5 (Figure 3E and Supplementary Figure 4B). The most
significant differences were evident in the extending tip, and
outer pinna mesenchyme, but reduced proliferation was also
evident in other regions of the pinna, suggesting a widespread
reduction in proliferation in the external ear (Supplementary
Figure 4B). To investigate whether the failure to extend the pinna
was also due to increased programmed cell death, we followed
activated Caspase 3 expression. No positive cells were identified
in the developing pinna in mutants or littermates controls at
E14.5 and E15.5 (Supplementary Figure 5) (N = 3). As a positive
control, apoptotic cells were observed in the ear canal during
normal development at E15.5 (Supplementary Figure 5F arrow),
agreeing with the literature (Nishizaki et al., 1998; Fons et al.,
2020). A reduction of proliferation, rather than an upregulation
of cell death, therefore, appeared to underlie the defect.
In order to understand the role of proliferation in pinna
development we then turned to a rolling culture technique to be
able to perturb this process (Figures 3J–M). Wild type embryonic
heads were divided down the midline and separated into two
groups for culture. One group of half heads were cultured in
the presence of the proliferation inhibitor Aphidicolin (2 µg/ml),
while the other half were cultured in control medium. Use of
Aphidicolin at this concentration has previously been shown to
lead to a global inhibition of proliferation in explant culture
(Yamada et al., 2019). Embryos older than E12.5 failed to develop
well in rolling culture, presumably due to the larger size of
the heads impacting on diffusion of nutrients, while in Trowel
culture on membranes the pinna flattened onto the head and
failed to extend. We therefore concentrated on E12.5. At E12.5
the pinna is an outgrowth that extends out perpendicular to the
head. By E13.5 the pinna bends anteriorly and starts to elongate
toward the prospective tragus (Figures 3J,K). After 2 days, we
checked the growth of the pinnae. In the controls, 11 (out of
16) pinnae grew and folded over mimicking the normal process
(Figures 3L,N). In contrast, none of the inhibitor-treated pinna
grew or bent, phenocopying the failed extension of the Fgf10
null mutant pinnae (Figures 3M,N, P = 0.002). This experiment
highlights the importance of cell proliferation for the bending and
the elongation of the pinna during development.
Fgf10 Regulates the MAP Kinase
Pathway During Pinna Elongation
FGF signaling regulates a number of pathways downstream of its
receptor, of which the MAP kinase (RAS/RAF/ERK1/2) pathway
is important in a number of developing organs, including
the pinna (Newbern et al., 2008). We therefore investigated
aspects of the RAS/ERK1/2 pathway. In control embryos at
E14.5, phospho-ERK (p-ERK) was present in the epithelium and
mesenchyme on the outer side of the pinna (Figures 4A–C,
asterisk in B), extending down the pinna to the tip (Figure 4C,
arrow). In contrast, expression was absent from the epithelial and
mesenchymal cells on the inner side of the pinna, and from the
Fgf10 expressing cartilage condensations in the middle of the
pinna (Figure 4B, arrowhead). In the absence of Fgf10, p-ERK
was reduced in the outer mesenchyme (Figures 4F,G, asterisk)
with patchy expression in the surface epithelium and no detection
of p-ERK at the tip (Figure 4H, arrow), highlighting the relevance
of this region to the failure to extend the pinna. Blood vessels
show up as autofluorescence in both cases and highlight the
vasculature running down the outer side of the pinna.
We then compared expression of p-ERK to that of the FGF
readouts Erm (Etv5) and Pea3 (Etv4). Both ETS transcription
factors are transcriptionally induced by FGF signaling but
can have different expression domains during development,
with Erm less restricted compared to Pea3 in the zebrafish
(Raible and Brand, 2001). Both Erm and Pea3 colocalized with
p-ERK in the outer regions of the pinna in the epithelium
and mesenchyme (Figure 4D,E, asterisk). However, Erm and
Pea3 were also expressed strongly in the inner regions of the
pinna (Figures 4D,E, arrowhead), in contrast with the lack of
p-ERK staining in this region (Figure 4B, arrowhead), suggesting
different molecular effectors operate between the outer and inner
regions of the pinna. In addition, Erm and Pea3 were expressed
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FIGURE 3 | Proliferation is required for the bending and elongation of the pinna. BrdU IF at E14.5 (A–D) and at E15.5 (F–I) in control littermates (A,B,F,G) and Fgf10
null mutant (C,D,H,I). There is a reduction in BrdU positive cells at the tip of the pinna (box in D,I) in the mutant. (E) Quantification of the percentage of BrdU positive
cells within the mesenchymal and epithelial at the tip of the pinna in the control and in the mutant at E14.5 and E15.5. E14.5 tip epithelium P = 0.0001. E14.5 tip
mesenchyme P = 0.0011. E15.5 tip epithelium P = 0.0061. E15.5 tip mesenchyme P = 0.019. (J,K) Control embryonic pinnae at E12.5 and at E13.5. The pinna
bends and elongates anteriorly. (L,M) Cultured whole pinnae in the presence (M) or absence (L) of the proliferation inhibitor Aphidicolin. After 2 days in culture, the
pinna bends and elongates as observed during embryonic development (compared to J,K). Inhibition of proliferation abolishes both bending and elongation (M).
(N) Quantification of the growth and bending observed in cultured pinnae. P = 0.002. P < 0.05 (*), P < 0.01 (**), P < 0.001 (***).
in the pinna muscle (Figures 4D,E) and Erm was expressed in the
forming cartilage (Figure 4D). Loss of Fgf10 in the mutant led to
a reduction of Erm and Pea3 expression across the pinna, with a
particularly strong downregulation in the outer epithelium and
mesenchyme, similar to that observed for p-ERK (Figures 4I,J,
asterisk). A robust loss of Erm expression in the mutants was also
observed at E15.5 (Supplementary Figure 6), with a reduction
of expression in the mesenchyme on the outer side of the pinna
cartilage. At E15.5 the loss of Erm in the inner pinna epithelium
was particularly striking.
Fgf10 Does Not Regulate BMP Signaling
Members of the BMP family have a role in pinna development
since mutations in either Bmp5 and Bmp4 lead to external ear
defects (King et al., 1994; Minoux et al., 2013). Mutations in
Bmp5 are responsible for the phenotype in the Short Ear mouse
(King et al., 1994), while a subset of Bmp4 hypomorphic mutant
mice display a similar phenotype to the one we describe here in
Fgf10 null mutants (Minoux et al., 2013). We therefore tested
for a possible genetic interaction between Fgf10 and Bmp4 and
5. Bmp5 was expressed all along the auricular cartilage (King
et al., 1994), but also was observed in the adjacent auricular
muscle (Figure 5A). Strong expression was maintained in the
Fgf10 mutant at E14.5 (Figure 5B). Bmp4 is expressed at the
base of the pinna and at the very tip of the extending pinna
(Figure 5C; Minoux et al., 2013). These two expression domains
were maintained in the Fgf10 mutant, with robust expression
at the base of the pinna (Figure 5D), in contrast to the lack
of p-ERK activity in this same region (Figure 4). Despite their
similar phenotype, we conclude that Fgf10 does not sit upstream
of the Bmp4/5 pathways.
DISCUSSION
In this study we have shown that Fgf10 controls pinna
development by inducing proliferation of both epithelial and
mesenchymal cells within the pinna, particularly at the tip,
leading to extension and shaping of the pinna. Loss of Fgf10
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FIGURE 4 | ERK1/2 is transducing Fgf10 signaling in the elongating pinna. IF for p-ERK1/2 at E14.5 in control littermates (A–C) and Fgf10 null mutant (F–H). (C,H)
High magnification of the tip of the pinna in (box in B,G). ERK1/2 are phosphorylated in the outer mesenchymal and epithelium (B,G, asterisk) and at the tip (C,H,
arrow) with an absence in the mutant. ISH for Erm (D,I) or Pea3 (E,J). Erm is expressed in the auricular muscle (m) and cartilage (c) and in the inner (D, arrow head)
and outer (D, asterisk) mesenchyme and epithelium with a reduction in expression in the mutant (I). Pea3 is expressed in the auricular muscle (m) and inner (E,
arrow head) and outer (E, asterisk) mesenchyme and epithelium with a reduction in expression in the mutant (J). c, cartilage; m, muscle.
resulted in smaller, malformed pinnae, correlating with the
dysmorphisms found in LADD syndrome, in which patients
show smaller, cup-shaped ears. This characteristic malformation
in patients is therefore likely to be explained by defects in
proliferation. A central role of proliferation in shaping the ear
is supported by our novel culture system of the whole pinna,
where experimental inhibition led to an arrest of bending and
elongation of the pinna at early stages of development.
One feature of murine pinna morphogenesis is the bending
of the initial outgrowth toward the prospective tragus, leading
to coverage of the ear canal. This rostral movement appears
distinct to mice and rats and may play a role in protecting
the ear canal during its development. In culture inhibition of
proliferation impairs bending, in addition to the elongation
of the tip. This suggests that proliferation, rather than
morphogenetic movements, such as convergent extension, drive
pinna morphogenesis. Higher proliferation on the outer part of
the pinna combined with lower proliferation in the inner part
of the pinna would be predicted to lead to an inwards bending.
However, we did not detect such differences in proliferation with
our BrdU labeling, but it might have been masked due to the
high incorporation index of BrdU in the ear, as expected from
a growing embryonic structure. Alternatively, a difference may
only be evident at earlier stages. As Fgf10 mutant mice had
normal development up to E14.5, the control of proliferation at
earlier stages must be provided by other signaling factors.
Analysis of Fgf10 expression using a LacZ reporter highlighted
expression in both the forming pinna muscle and a subset
of neural crest derived cartilage cells. Ablation of Fgf10
specifically in the neural crest did not affect pinna development,
in comparison with the null mutant. This suggests that
mesodermally derived Fgf10 is sufficient for pinna elongation. In
this case the mesodermally derived Fgf10 appears to be able to
compensate for loss of Fgf10 in the forming cartilage. Conditional
knockout of Fgf10 in the pinna mesoderm would be an important
next step in order to investigate whether the phenotype is driven
solely by loss of Fgf10 from the mesoderm.
The FGF canonical pathway ERK is an essential transducer
of FGF signaling in a variety of tissues, including salivary
glands (Chatzeli et al., 2017). Our data shows that ERK 1/2
also transduces Fgf10 signaling in the pinna, with loss of
p-ERK in the cells lateral to the Fgf10 expressing cartilage
and muscle, and at the tip of the pinna in the mutant.
Interestingly, differential p-ERK was observed between the outer
and inner part of the elongating pinna at E14.5, suggesting
that cells on the outer part of the pinna might be more
responsive to Fgf10 signaling than those on the inner side.
The expression of the FGF readouts Erm and Pea3, however,
did not match the expression of p-ERK, and showed high
levels of expression in the inner pinna epithelium, which was
dramatically reduced in the mutant. In keeping with the wider
expression of Erm and Pea3, a reduction of proliferation was
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FIGURE 5 | Bmp4/5 are not regulated by Fgf10. ISH for Bmp5 (A,B) and
Bmp4 (C,D) in control litermates (A,C) and Fgf10 null mutant (B,D). Bmp5 is
expressed at the base of the pinna moving into the pinna itself (arrow head in
A). Bmp4 is expressed in the basal cartilage (arrow heads, C,D) and at the
very tip of the pinna (A, arrow). Fgf10 null mutants maintain expression of both
Bmp5 (B) and Bmp4 (D).
identified in both the inner and outer tissue in the Fgf10
mutants. Interestingly, Erm and Pea3 had slightly different
expression patterns, suggesting that Erm and Pea3 respond to
different thresholds or follow different kinetics using the same
signal (Raible and Brand, 2001). In zebrafish, for example, Erm
required a lower level of FGF signaling for activation than Pea3
(Roehl and Nusslein-Volhard, 2001).
The difference in ERK 1/2 phosphorylation suggests that
the pinna is compartmentalized, with both a medial-lateral and
proximo-distal axis. Indeed, differential gene expression has been
shown between these axis with Prx1 expressed in the inner region
of the elongating pinna and absent in the outer region, while
Bmp4 and Hoxa2 are differentially expressed along the proximo
distal axis (Minoux et al., 2013). These axes are likely to be
important in directing pinna morphogenesis.
The essential role of ERK pathway in pinna development
is highlighted by the ERK conditional knock out in the
cranial neural crest (Newbern et al., 2008). This mutant
mouse displays a severe malformation of the external ear
or anotia (lack of pinna). In contrast, the Fgf10 mutant
shows a much milder pinna phenotype, suggesting that Fgf10
is not the only ligand that activates ERK1/2, particularly
at earlier stages. Fgf8 induces ERK 1/2 activation and the
pinna is missing or defective in Fgf8 compound heterozygous
mutants (Abu-Issa et al., 2002; Moon et al., 2006). Therefore,
Fgf8 could be playing a role at earlier stages of pinna
development, and may compensate for the loss of Fgf10 at
later stages. In keeping with this, the expression of FGF
readouts Erm and Pea3 were reduced but not abolished in the
Fgf10 mutants.
Previous studies have reported a role of Fgf10 signaling in
cranial muscle differentiation (Sugii et al., 2017). Fgf10, Erm,
and Pea3 were expressed in the pinna muscle, suggesting a
potential role for Fgf10 in the differentiation of these tissues.
In keeping with this, Fgf10 has been shown to act downstream
of Tbx1, with loss of Tbx1 leading to muscle defects (Kelly
et al., 2004). However, the differentiated muscle marker 12–
101 was unaffected in the Fgf10 mutant pinna, indicating that
muscle was able to differentiate as normal in the absence
of Fgf10. Therefore, either Fgf10 is not involved in auricular
muscle differentiation or other FGFs present in the pinna can
compensate for its loss.
Others growth factors involved in cartilage differentiation and
pinna development are members of the BMP family. A subset
of Bmp4 hypomorph mutant show a similar phenotype to
the Fgf10 mutant phenotype we describe here, with the pinna
failing to elongate, leaving the ear canal exposed (Minoux et al.,
2013). Bmp5 mutants display small and microtic ears (King
et al., 1994). Both genes are expressed in the cartilaginous
condensations of the pinna (Minoux et al., 2013) overlapping
with Erm/Pea3. In the lung epithelium, Fgf10 regulates Bmp4
expression (Abler et al., 2009). In the pinna of the Fgf10
mutant, however, Bmp4/5 expression was still present, suggesting
that Fgf10 does not sit upstream of Bmp4/5 during pinna
development. It is possible, however, that FGF signaling
is regulated by Bmp signaling, thus an analysis of Fgf10
expression in the pinna of Bmp4 and 5 mutants would be an
interesting next step.
Fgf10 in the pinna is likely to act through Fgfr2b given
the pinna defect in patients with mutations in both parts
of the pathway (Milunsky et al., 2006; Rohmann et al.,
2006). The expression of Fgfr2b has not been followed in
the pinna but this receptor is strongly expressed in cranial
epithelium, with weaker mesenchymal expression described
in areas such as the forming palate (Rice et al., 2004).
The potential expression in both epithelium and mesenchyme
suggests that Fgf10 could directly signal to both epithelial and
mesenchymal tissue. The pinna has not been studied in the
Fgfr2b knockout (De Moerlooze et al., 2000), but a similar
defect might be predicted given the overlap in phenotypes
between the Fgf10 and Fgfr2b mouse mutants. Interestingly
a pinna defect has been noted in mice with a missense
mutation in Fgfr1, known as hush puppy (Calvert et al., 2011).
Fgfr1b can act as a receptor for Fgf10, in addition to Fgfr2b
(Watson and Francavilla, 2018). Hush puppy heterozygotes have
small misshapen and low set ears similar to LADD syndrome
patients (Calvert et al., 2011). Fgfr1 homozygous hypomorphs
also have a very reduced pinna (Trokovic et al., 2003). It is,
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therefore, possible that Fgf10 acts through both Fgfr2b and
Fgfr1b during pinna development.
CONCLUSION
In conclusion, our data provide a novel insight in the molecular
mechanisms underpinning microtia in LADD syndrome and
provides the base for future studies in microtia research.
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Supplementary Figure 1 | Counting method for serial sections of pinna. To
quantify the numbers of proliferating cells a fixed region was initially defined at the
tip of the extending pinna at E14.5 and E15.5. (A) A dotted line was drawn at the
boundary between the epithelium and mesenchymal layers of the pinna. Twenty
mesenchymal cells outlined by DAPI were then counted in an arc along this dotted
line, with 10 cells on each side of the arc (blue dots highlight nuclei along the
dotted line). The limit of the area was then further defined by addition of lines
around and through the tip. (B) BrdU positive mesenchymal cells within the yellow
domain, and BrdU positive epithelial cells within the pink domain were then
counted. To quantify the inner and outer sides of the pinna. We selected an area 5
cells away from the tip region previously counted. An area the height of 10 cells
was then selected and the epithelial and mesenchmal cells within
that area counted.
Supplementary Figure 2 | Pinna cartilage is formed by neural crest derived
mesenchyme. (A–F) E15.5 pinna. Neural crest derived tissue in red. (B,F) The
pinna epithelium is not labeled by Wnt1creTom and expresses Sox9 (green)
(B,D,F) Sox9 expression in green. 12–101 muscle expression in blue. Boxed
areas in (B) shown in (C–F). Sox9 is expressed in the developing cartilage and
pinna epithelium. (C,D) The Sox9 cells within the pinna overlap with the neural
crest marker in the region of the forming cartilage. (E,F) The forming muscle does
not overlap with the neural crest marker, in contrast to the mesenchymal Sox9.
Supplementary Figure 3 | Cleft palate in Wnt1creFgf10flfl embryos. (A) Cre
negative Fgf10 flfl control mouse showing a closed palate at E18.5. (B)
Wnt1creFgf10flfl mutant mouse showing failure of palate formation at E18.5.
Supplementary Figure 4 | Reduced proliferation throughout the pinna in Fgf10
mutants. (A) Pinna at E15.5 showing BrdU positive cells. Boxed areas on either
side of the pinna indicate the region counted. (B) Graphs comparing number of
proliferating cells. E14.5 inner epithelium P = 0.011. E14.5 outer epithelium
P = 0.0361. E14.5 inner mesenchyme P = 0.1578. E14.5 outer mesenchyme
P = 0.01. E15.5 inner epithelium P = 0.0675. E15.5 outer epithelium P = 0.0169.
E15.5 inner mesenchyme P = 0.0154. E15.5 outer mesenchyme P = 0.0015.
P < 0.05 (∗), P < 0.01 (∗∗).
Supplementary Figure 5 | Fgf10 loss of function does not lead to an increase in
cell death. IF for cleaved caspase 3 at E14.5 (A–D) and E15.5 (E–H) in control
littermates (A,B,E,F) and Fgf10 null mutant (C,D,G,H). There are no apoptotic
cells in the pinna at both stages. However, as a positive control, positive cells were
evident within the ear canal at E15.5 as previously reported (F, arrow). Lack of
Fgf10 signaling does not increase apoptosis at the tip of the pinna (A′,C′,E′,G′).
The green dots are autofluorescence cells.
Supplementary Figure 6 | Downregulation of Erm at E15.5 in Fgf10 mutants.
(A,B) Erm in situ hybridization at E15.5. (A) Fgf10 control littermate, (B)
Fgf10 mutant.
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